- CEO
- Makoto Inoue
- Full Time Employees
- 58
- Sector
- Producer manufacturing
- Industry
- Metal fabrication
- Address
- 27-27, Tsurutacho Osaka OS Japan 593-8323
- IPO Date
- Jun 24, 2015
- Business
- Nakamura Choukou Co., Ltd. develops, manufactures, and sells precision equipment, electronic material slicing peripherals, chemical fiber spinning nozzles, and related products primarily in Japan. The company offers diamond wire cutting tools such as DINA-PRISM for slicing electronic materials used in solar batteries and LEDs, PHX-01 diamond wire manufacturing equipment, wear-resistant parts made from PCD sintered diamond, cemented carbide, and ceramics for bearings, electronics, and machine tools; adsorption nozzles for electronic part mounting, automatic nozzle cleaners including MAC-I, MAC-III, and Eco-Clean MM-7060; micro reactor items such as automated flow reactors X-1, micromixers, and mass flow controllers; spinnerets, precision parts, and machinery units for synthetic and chemical fibers including meltblown and spunlace nonwoven fabrics; industrial equipment like shower plates, fuel injectors, medical devices, and filters; as well as spinneret cleaning equipment, detergents, and nano-sized zeolite powder production methods. It operates through the Electronic Material Slice Periphery segment, High-Precision Equipment segment, and Chemical Fiber Spinning Nozzle segment, serving industries including electronics, machine tools, synthetic fibers, solar power, and pharmaceuticals, with facilities in Osaka including the MAC Center headquarters in Sakai City and D-Next factories in Izumi City, a factory in Okinawa, a trading subsidiary in Shanghai, China, and a wholly-owned subsidiary Nippon Nozzle Co., Ltd. Nakamura Choukou Co., Ltd., founded in 1954 with Nakamura Steel Works as its predecessor and formally established in 1970, is headquartered at 27-27 Tsurutacho, Nishi-ku, Sakai City, Osaka. Recent developments include ongoing joint research progress announced in March 2023 with Chiba University's Laboratory of Medicinal Chemistry on synthesizing PIP organic compounds for cancer drug discovery using its flow synthesis system, confirming reproducibility in dimer, trimer, and tetramer structures; a technical collaboration agreement in the diamond-wire business in March 2022; establishment of a new subsidiary as noted in recent financial updates; and release of its latest company brochure in July 2022.